Companies
CellulaREvolution
a UK originator that developed dynamically cultured, differentiated bovine adipose-derived stem cell spheroids as building blocks for biofabricating cultured fat, but entered administration, with its IP and assets subsequently put up for sale.
- Country
- United Kingdom
Coverage
| EU | US | |
|---|---|---|
| food-alt-protein | ✓ | ✓ |
Regulatorsfda
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Raised more than £4 million in total investment between 2018 and 2023 | thespoon.tech · business-live.co.uk · northstarventures.co.uk |
| Revenue | Pre-revenue generation as of August 2025 | hilcovs.co.uk |
| Headcount | Eight employees as of March 2023 | newcastlehelix.com |
| Headcount | Nine jobs lost upon entering administration in August 2025 | business-live.co.uk |
| Production site | The Biosphere, Newcastle Helix, Newcastle, United Kingdom | newcastlehelix.com |
Independent sources: business-live.co.uk · hilcovs.co.uk · newcastlehelix.com · northstarventures.co.uk · thespoon.tech
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cellular fats and cultured lipids | food-alt-protein | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.